Navigation Links
Gen-Probe and Novartis Agree to Extend and Expand Blood Screening Collaboration
Date:1/27/2009

to help fund development of Gen-Probe's PANTHER instrument, a fully automated molecular testing platform, for the blood screening market. The companies also have agreed to evaluate, using Gen-Probe's technologies, the development of companion diagnostics for current or future Novartis medicines.

Gen-Probe Preliminary 2009 Financial Guidance

Gen-Probe expects the new agreement to add to the Company's revenue and profits in 2009 and future years. Accordingly, Gen-Probe's preliminary expectation is that its total revenues in 2009 will range from $460 to $490 million, and that its earnings per share will range from $1.80 to $2.05. These preliminary ranges incorporate foreign exchange rate fluctuations approximately 10% higher or lower than recent levels, and do not yet include potential revenue from the new PROCLEIX ULTRIO assay in the United States.

About Gen-Probe

Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has more than 25 years of NAT expertise, and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing NAT assays for blood screening. Gen-Probe is headquartered in San Diego and employs approximately 1,000 people. For more information, go to http://www.gen-probe.com.

Caution Regarding Forward-Looking Statements

Any statements in this press release about Gen-Probe's expectations, beliefs, plans, objectives, assumptions or future events or performance, including those under the heading "Gen-Probe Preliminary 2009 Financial Guidance," are not historical facts and are forward-looking statements. These statements are often, but not alw
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Eric Tardif Joins Gen-Probe as Senior Vice President, Corporate Strategy
2. Gen-Probe to Webcast Presentation at the 27th Annual J.P. Morgan Healthcare Conference
3. Gen-Probe to Webcast Presentation at the 20th Annual Piper Jaffray Health Care Conference
4. Gen-Probe Reports Strong Financial Results for Third Quarter 2008, Raises Full-Year EPS Guidance
5. Gen-Probe Announces Webcasts of Three Upcoming Investor Events
6. Gen-Probe to Webcast Two Upcoming Investor Presentations
7. Gen-Probe Announces Webcast of First Quarter 2008 Earnings Conference Call
8. Gen-Probe to Webcast Presentation at Leerink Swann Molecular Diagnostics Conference
9. Gen-Probe to Webcast Presentation at Deutsche Bank Small- and Mid-Cap Growth Conference
10. Gen-Probe to Webcast Presentation at 26th Annual JPMorgan Healthcare Conference
11. Gen-Probe to Webcast Presentation at NASDAQ 20th Investor Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... New York, New York (PRWEB) May 23, 2013 ... dedicated to protecting the rights of victims injured by ... that Senior Litigation Counsel Matthew J. McCauley has been ... entitled In Re: Mirena IUD Products Liability Litigation (Case ... states that Co-Lead and Liaison Counsel are to submit ...
(Date:5/23/2013)... CA (PRWEB) May 23, 2013 EnvirOasis, ... the contractor and ESCO market is pleased to announce ... Consortium (DLC) Listed LED products. EnvirOasis has been ... fixtures and retrofit kits and has recently brought ... LED (Light Emitting Diode) is energy efficient lighting ...
(Date:5/23/2013)... News) -- The sensation of itching is hardwired into ... a small molecule released in the spinal cord, according ... say this molecule, known as natriuretic polypeptide b (Nppb), ... system. Ultimately, this signal is experienced as an itch. ... similar, the researchers concluded that a similar process probably ...
(Date:5/23/2013)... May 23 (HealthDay News) -- Teen birth rates in the ... to a new government report. Overall, the rate of ... one half from 1991 to 2011 -- from about 62 ... 1,000. From 2007 to 2011, the most recent time ... 31. During that time, rates fell at least 30 ...
(Date:5/23/2013)... (HealthDay News) -- A shortage of a critical tuberculosis ... the United States to contain the spread of the ... drug, isoniazid (INH), was first used in 1951 and ... core of any first-line treatment for tuberculosis (TB). Patients ... according to the U.S. Centers for Disease Control and ...
Breaking Medicine News(10 mins):Health News:U.S. District Court Appoints Parker Waichman LLP’s Matthew J. McCauley to Leadership Role in Mirena IUD Litigation 2Health News:EnvirOasis Lighting Announces Energy Star and Design Lights Consortium LED Products 2Health News:Got an Itch? Mouse Study May Help Explain Why 2Health News:U.S. Teen Birth Rate Plummets: Report 2Health News:U.S. Teen Birth Rate Plummets: Report 3Health News:Shortage of Key Drug Hampering U.S. Efforts to Control TB: Report 2
... good job of aggressively treating the early stages of ... diagnosis. The study involved 467 hospitals spread across 12 ... that patients may be treated less aggressively when they ... able to confirm the diagnosis,” said Chadwick Miller, M.D., ...
... Heart failure patients with untreated sleep apnea are more likely to ... ,The study followed 164 patients with heart failure for ... apnea (OSA) had double the death rate of those patients who ... OSA, the death rate was 24% in contrast to 12% for ...
... in the fight against obesity has started delivering results in ... pilot program was started in one of the middle schools ... eating habits among school children. ,Today nearly ... this three year old program called ‘Healthy School.’ ...
... that smoking and binge drinking among teenage girls have ... the health risks seem less important than those of ... young people correctly see cigarettes and alcohol as a ... to reflect that, Ofsted opined. Pupils also felt let ...
... NHS services’, UK ‘s Health Minister Patricia Hewitt launched ... select their hospital and doctor, as well as access information on ... to put patients at the heart of the NHS and making ... a crucial part of that. “Patients will soon be able to ...
... welcomed the Government’s decision to officially recognise the Australian ... for rural GPs. ,“Rural GPs are the ... ,“Formal recognition for rural GPs who complete ... workforce in rural and regional areas.” ,The ...
Cached Medicine News:Health News:Doctors Treat Early Heart Attacks Before Labs Could Confirmation It 2Health News:Doctors Treat Early Heart Attacks Before Labs Could Confirmation It 3Health News:Sleep Disorder Linked to Heart Failure Patient Deaths 2Health News:Sleep Disorder Linked to Heart Failure Patient Deaths 3Health News:Campaign Against Obesity Taken to Schools in US 2Health News:Parents To Blame For Soaring Counts Of Binge-Drinkers And Smokers 2Health News:NHS Online- Promise Of ‘Choices’ To Patien 2
(Date:5/23/2013)... 2013  Every day, their baby stopped breathing, his collapsed ... April and Bryan Gionfriddo watched helplessly, ... "Quite a few doctors said he had a good ... April Gionfriddo , about her now 20-month-old son, Kaiba. ... we would take it and run with it." ...
(Date:5/23/2013)... TARRYTOWN, N.Y. , May 23, 2013 /PRNewswire/ ... reconstruction following mastectomy is an appropriate option ... mutations seeking to surgically reduce their breast cancer ... involves a gradual expansion process and a second ... of implants in the same surgery as mastectomy ...
(Date:5/23/2013)... Israel , May 23, 2013 ... BrainTech Israel 2013 , Israel,s 1 ... on October 14 th -15 th in ... most innovative city in the world by the ... Nation." BrainTech Israel 2013 will showcase the latest ...
Breaking Medicine Technology:Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 4Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 2Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 3Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 2Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 3
... Advanced Life Sciences,Holdings, Inc. (Nasdaq: ADLS ... with the National Institute of Allergy and ... biodefense,research, under which the NIAID will conduct ... as a treatment for,anthrax and other high-priority ...
... Compound, AHLi-11, Slated for IND Filing By ... ... Quark Pharmaceuticals, Inc., a,clinical-stage biopharmaceutical company focused on discovering and,developing novel ... the State University of New York at,Buffalo, Center for Hearing & ...
Cached Medicine Technology:Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents 2Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents 3Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents 4Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss 2Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss 3Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss 4